Symbol | Exchange | Currency |
|---|
Investing.com – U.S. stocks were mixed after the close on Friday, as gains in the Telecoms, Consumer Services and Healthcare sectors led shares higher while losses in the Oil &...
Investing.com – U.S. stocks were mixed after the close on Thursday, as gains in the Telecoms, Financials and Consumer Services sectors led shares higher while losses in the Oil &...
Investing.com – U.S. stocks were lower after the close on Monday, as losses in the Oil & Gas, Technology and Industrials sectors led shares lower. At the close in NYSE, the Dow...
Intuitive Surgical Inc. (NASDAQ:ISRG) posted adjusted earnings of $2.77 per share in the third quarter of 2017, crushing the Zacks Consensus Estimate of $1.97 on stellar revenue...
athenahealth Inc. (NASDAQ:ATHN) reported adjusted earnings of 56 cents per share in the third quarter of fiscal 2017, steering past the Zacks Consensus Estimate of 50 cents....
For Immediate ReleaseChicago, IL – October 09, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts...
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 76.47 | 78.91 | 75.48 | -1.52 | -1.95% | 104.55M | NASDAQ | |||
| 37.90 | 39.67 | 37.71 | -2.97 | -7.27% | 15.54M | NASDAQ | |||
| 166.66 | 167.58 | 165.63 | -0.07 | -0.04% | 6.25M | NASDAQ | |||
| 61.80 | 62.71 | 59.43 | -1.27 | -2.01% | 8.45M | NASDAQ | |||
| 7.18 | 7.54 | 7.06 | -0.36 | -4.77% | 6.11M | NYSE | |||
| 35.07 | 35.28 | 33.96 | -0.24 | -0.68% | 8.24M | NYSE | |||
| 45.76 | 47.80 | 45.64 | -2.00 | -4.19% | 2.79M | NYSE | |||
| 12.07 | 12.60 | 11.95 | -1.25 | -9.38% | 8.14M | OTC Markets | |||
| 143.79 | 144.44 | 141.23 | +1.59 | +1.12% | 7.34M | NYSE | |||
| 0.973 | 0.9975 | 0.95 | -0.0270 | -2.70% | 6.52M | NYSE | |||
| 0.1234 | 0.132 | 0.1202 | -0.0031 | -2.45% | 2.95M | NYSE | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 165.04 | 167.50 | 161.11 | -5.57 | -3.26% | 9.46M | NYSE | |||
| 12.75 | 12.87 | 12.24 | -0.23 | -1.77% | 8.70M | NYSE | |||
| 25.14 | 26.09 | 25.06 | -1.06 | -4.05% | 1.43M | NYSE |